Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

The impact of postoperative complications on the administration of adjuvant therapy following pancreaticoduodenectomy for adenocarcinoma.

Wu W, He J, Cameron JL, Makary M, Soares K, Ahuja N, Rezaee N, Herman J, Zheng L, Laheru D, Choti MA, Hruban RH, Pawlik TM, Wolfgang CL, Weiss MJ.

Ann Surg Oncol. 2014 Sep;21(9):2873-81. doi: 10.1245/s10434-014-3722-6. Epub 2014 Apr 26.

PMID:
24770680
[PubMed - in process]
2.

Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.

Yeo CJ, Abrams RA, Grochow LB, Sohn TA, Ord SE, Hruban RH, Zahurak ML, Dooley WC, Coleman J, Sauter PK, Pitt HA, Lillemoe KD, Cameron JL.

Ann Surg. 1997 May;225(5):621-33; discussion 633-6.

PMID:
9193189
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

A single institution review of adjuvant therapy outcomes for resectable pancreatic adenocarcinoma: outcome and prognostic indicators.

Kim R, Tsao R, Tan A, Byrne M, Almhanna K, Lazaryan A, Elson P, Pelley RJ.

J Gastrointest Surg. 2010 Jul;14(7):1159-69. doi: 10.1007/s11605-010-1213-z. Epub 2010 May 6.

PMID:
20446118
[PubMed - indexed for MEDLINE]
4.

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.

Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, Sauter PK, Coleman J, Hruban RH, Lillemoe KD.

J Gastrointest Surg. 2000 Nov-Dec;4(6):567-79.

PMID:
11307091
[PubMed - indexed for MEDLINE]
5.

Outcomes of adjuvant chemoradiation after pancreaticoduodenectomy with mesenterico-portal vein resection for adenocarcinoma of the pancreas.

Hristov B, Reddy S, Lin SH, Cameron JL, Pawlik TM, Hruban RH, Swartz MJ, Edil BH, Kemp C, Wolfgang CL, Herman JM.

Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):176-80. doi: 10.1016/j.ijrobp.2009.01.047. Epub .

PMID:
19394156
[PubMed - indexed for MEDLINE]
6.

Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital.

Herman JM, Swartz MJ, Hsu CC, Winter J, Pawlik TM, Sugar E, Robinson R, Laheru DA, Jaffee E, Hruban RH, Campbell KA, Wolfgang CL, Asrari F, Donehower R, Hidalgo M, Diaz LA Jr, Yeo C, Cameron JL, Schulick RD, Abrams R.

J Clin Oncol. 2008 Jul 20;26(21):3503-10. doi: 10.1200/JCO.2007.15.8469.

PMID:
18640931
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma.

Pendurthi TK, Hoffman JP, Ross E, Johnson DE, Eisenberg BL.

Am Surg. 1998 Jul;64(7):686-92.

PMID:
9655283
[PubMed - indexed for MEDLINE]
8.

Prognostic factors and adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma.

You DD, Lee HG, Heo JS, Choi SH, Choi DW.

J Gastrointest Surg. 2009 Sep;13(9):1699-706. doi: 10.1007/s11605-009-0969-5. Epub 2009 Jul 7.

PMID:
19582512
[PubMed - indexed for MEDLINE]
9.

The influence of prognostic factors and adjuvant chemoradiation on survival after pancreaticoduodenectomy for ampullary carcinoma.

Showalter TN, Zhan T, Anne PR, Chervoneva I, Mitchell EP, Yeo CJ, Rosato EL, Kennedy EP, Berger AC.

J Gastrointest Surg. 2011 Aug;15(8):1411-6. doi: 10.1007/s11605-011-1518-6. Epub 2011 Apr 27.

PMID:
21523621
[PubMed - indexed for MEDLINE]
10.

Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.

Chakravarthy A, Abrams RA, Yeo CJ, Korman LT, Donehower RC, Hruban RH, Zahurek ML, Grochow LB, O'Reilly S, Hurwitz H, Jaffee EM, Lillemoe KD, Cameron JL.

Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):1089-96.

PMID:
11072167
[PubMed - indexed for MEDLINE]
11.

Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas.

Spitz FR, Abbruzzese JL, Lee JE, Pisters PW, Lowy AM, Fenoglio CJ, Cleary KR, Janjan NA, Goswitz MS, Rich TA, Evans DB.

J Clin Oncol. 1997 Mar;15(3):928-37. Review.

PMID:
9060530
[PubMed - indexed for MEDLINE]
12.

A neoadjuvant strategy for pancreatic adenocarcinoma increases the likelihood of receiving all components of care: lessons from a single-institution database.

Piperdi M, McDade TP, Shim JK, Piperdi B, Kadish SP, Sullivan ME, Whalen GF, Tseng JF.

HPB (Oxford). 2010 Apr;12(3):204-10. doi: 10.1111/j.1477-2574.2009.00150.x.

PMID:
20590888
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas.

Lee JH, Whittington R, Williams NN, Berry MF, Vaughn DJ, Haller DG, Rosato EF.

Int J Radiat Oncol Biol Phys. 2000 Jul 1;47(4):945-53. Review.

PMID:
10863064
[PubMed - indexed for MEDLINE]
14.

Pancreatoduodenectomy associated complications influence cancer recurrence and time interval to death.

van der Gaag NA, Harmsen K, Eshuis WJ, Busch OR, van Gulik TM, Gouma DJ.

Eur J Surg Oncol. 2014 May;40(5):551-8. doi: 10.1016/j.ejso.2013.12.012. Epub 2013 Dec 25.

PMID:
24388408
[PubMed - indexed for MEDLINE]
15.

Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct.

Hughes MA, Frassica DA, Yeo CJ, Riall TS, Lillemoe KD, Cameron JL, Donehower RC, Laheru DA, Hruban RH, Abrams RA.

Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):178-82. Epub 2007 Feb 2.

PMID:
17276614
[PubMed - indexed for MEDLINE]
16.

Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis.

Showalter TN, Rao AS, Rani Anne P, Rosato FE, Rosato EL, Andrel J, Hyslop T, Xu X, Berger AC.

Ann Surg Oncol. 2009 Aug;16(8):2116-22. doi: 10.1245/s10434-009-0498-1. Epub 2009 May 13.

PMID:
19437078
[PubMed - indexed for MEDLINE]
17.

Severe postoperative complications adversely affect long-term survival after R1 resection for pancreatic head adenocarcinoma.

Petermann D, Demartines N, Schäfer M.

World J Surg. 2013 Aug;37(8):1901-8. doi: 10.1007/s00268-013-2023-8.

PMID:
23564215
[PubMed - indexed for MEDLINE]
18.

The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.

Jolly S, Vargas CE, Kumar T, Weiner SA, Brabbins DS, Chen PY, Floyd W, Martinez AA.

Gynecol Oncol. 2006 Oct;103(1):87-93. Epub 2006 Mar 20.

PMID:
16545441
[PubMed - indexed for MEDLINE]
19.

[Prognostic clinical factors in colorectal cancer after radical therapy].

Novák P, Liska V, Treska V, Kopalová J, Vycítal O, Brůha J.

Rozhl Chir. 2012 Apr;91(4):219-29. Czech.

PMID:
22880270
[PubMed - indexed for MEDLINE]
20.

Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.

Hsu CC, Herman JM, Corsini MM, Winter JM, Callister MD, Haddock MG, Cameron JL, Pawlik TM, Schulick RD, Wolfgang CL, Laheru DA, Farnell MB, Swartz MJ, Gunderson LL, Miller RC.

Ann Surg Oncol. 2010 Apr;17(4):981-90. doi: 10.1245/s10434-009-0743-7. Epub 2010 Jan 20.

PMID:
20087786
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk